Press Room

Webinar - Nasal powder delivery: Process, formulation and analytical characterization

Start
Thursday, November 30, 2023 - 16:00
End
Thursday, November 30, 2023 - 18:00
Location: Online

Thursday, November 30th, 2023

11:00 am EDT | 4:00 pm GMT | 5:00 pm CEST | 8:00 am PDT

 

Register now

Registrations to the webinar are subject to approval.

 

Featured Hovione experts in this webinar
Webinar_Speakers_Patricia Henriques_Hovione
Webinar_Speakers_Antonio Serodio
Patrícia Henriques, M.Sc.
Scientist
Inhalation and Advanced Drug Delivery
Hovione
António Serôdio, M.Sc.
Analytical Scientist
Analytical Development
Hovione

 

This webinar will address the most relevant solutions for nasal powder development covering both process and formulation optimization, as well as the analytical characterization, under an integrated development approach. 

Powders for nasal delivery have been recognized as advantageous dosage forms over liquids due to increased stability and residence time on nasal mucosa, with improved bioavailability. However, the scientific community still struggles with the existing gaps between formulation composition, particle engineering and nasal absorption. 

This presentation will cover different formulation platforms, focusing on the delivery of poorly soluble drugs, aiming to address the pharmacokinetics requirements of the target drug and indication. Different particle engineering strategies including spray drying and process optimization will be addressed, as well as physical and chemical characterization of nasal powders and advanced performance characterization methodologies that are able to predict in vivo behavior in nasal powder early development. The formulation-process-performance integrated approach is designed to maximize rate and extent of drug absorption while maintaining safety, being able to address a diversified array of diseases. 
Register today!

 

Key Learning Objectives:

  • Gain insights on novel formulation development strategies for nasal powders, able to deliver drugs with challenging physicochemical profiles;
  • Understand the potential of spray drying capabilities for boosting targeted nasal delivery of powders; 
  • Discover analytical characterization techniques, for differentiated formulations, to further understand product properties that affect drug delivery;
  • Understand the analytical characterization methodologies for nasal powders;
  • Understand advanced performance methodologies that correlate with in vivo absorption; 
  • Interact with our experts during the live Q&A session.

Who Should Attend:

  • Pharmaceutical researchers and scientists
  • CMC experts on inhalation/nasal drug delivery
  • Business development, portfolio management and technology licensing experts
  • Inhalation product development professionals and therapeutics specialists

Register now and get involved

 

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025